Recurrent Spontaneous Bacterial Peritonitis Research Articles

Predictive factors of recurrence in spontaneous bacterial peritonitis in Tunisian patients with cirrhosis.

Recurrent spontaneous bacterial peritonitis (SBP) in patients with cirrhosis is associated with poor prognosis. To assess the prevalence and the risk factors for recurrence and to evaluate its impact on the prognosis. We conducted a retrospective study including patients with cirrhosis having a first episode of SBP. A recurrence of SBP was identified in 43.4% of the patients who survived after a first episode of SBP. The mean time to onset of the first SBP recurrence from the first episode was 32days. Recurrence factors were endoscopic hypertensive signs, a positive ascites culture, diarrhea and the MELD score. There was no impact on survival of recurrent SBP compared with the first SBP episode.

The Predictors of Hepatorenal Syndrome Development in HCV Cirrhotic Ascitic Egyptian Patients with Spontaneous Bacterial Peritonitis.

Spontaneous bacterial peritonitis is considered a precipitating factor for renal impairment in patients with liver cirrhosis. No specific study addressing this problem has been reported. This study aimed to detect the incidence and predictive factors of hepatorenal syndrome in these patients. This study enrolled 121 hepatic cirrhotic patients with spontaneous bacterial peritonitis. History taking, clinical examination, and laboratory investigations including ascitic fluid analysis were carried out. Kidney function tests were repeated 3 days after the initiation of treatment. Patients were divided into 2 groups after one week of treatment during the follow-up period: Group I: patients without hepatorenal syndrome, and Group II: patients with hepatorenal syndrome. Multivariate analysis was performed to determine independent predictors of hepatorenal syndrome development. A total of 30 patients (24.8%) developed hepatorenal syndrome. Patients with hepatorenal syndrome had significantly lower sodium and albumin levels as well as higher creatinine, bilirubin, Child-Turcotte-Pugh score, portal vein diameter, Model for End-Stage Liver Disease score. Higher percentage of them had a history of recurrent spontaneous bacterial peritonitis and multiple therapeutic paracentesis of ascites. Multivariate analysis detected that serum bilirubin, Model for End-Stage Liver Disease-Sodium, and portal vein diameter were significant predictors of hepatorenal syndrome. Cutoff values were determined as 3.3 mg/dl for bilirubin, 15.9 mm for portal vein diameter, and 26 for Model for End-Stage Liver Disease-Sodium. Hepatorenal syndrome is a common complication of spontaneous bacterial peritonitis. In our study, high serum bilirubin, Model for End-Stage Liver Disease-Sodium, and portal vein diameter are predictors of the development of hepatorenal syndrome in patients with spontaneous bacterial peritonitis.

Outcomes in patients with spontaneous bacterial peritonitis utilizing first-line or alternative agents for secondary prophylaxis.

The American Association for the Study of Liver Diseases guidelines recommend ciprofloxacin as a first-line option for spontaneous bacterial peritonitis (SBP) prophylaxis, citing literature that is over 30 years old. There is insufficient data and guidance for prophylaxis in cases of fluoroquinolone treatment failure or intolerance. This study aimed to evaluate outcomes in patients whose antimicrobial prophylaxis was switched from first-line therapies to an alternative agent versus those who were not switched following recurrent SBP. This study was an institutional review board-approved retrospective chart review of patients admitted to University of Kentucky HealthCare from 2014 through 2020. Patients included were 18 years of age or older with a diagnosis of recurrent SBP. The primary outcome examined was SBP recurrence rate following initial prophylaxis failure. Additional analyses targeted secondary outcomes, including 6-month mortality, development of SBP complications, development of an adverse drug reaction, and development of multidrug-resistant pathogens. Fifty-three patients were identified with recurrent SBP and divided into 2 cohorts: 25 patients were switched from their original prophylactic agent while 28 patients continued on the same agent after SBP recurrence. Patients in the switch group had lower rates of recurrence (52% vs 100%). Additionally, these patients had lower 6-month mortality rates (24% vs 57.1%; P = 0.015). Thirteen patients in the no-switch group and 3 patients in the switch group required intensive care on a subsequent admission (46.4% vs 12%; P = 0.008). There were no significant differences between the groups in rates of other SBP complications. Patients switched from their original prophylactic agent had lower rates of SBP recurrence with significantly lower 6-month mortality rates.

Efficacy predictors of third-generation cephalosporins in treating spontaneous bacterial peritonitis.

Objective:Third-generation cephalosporins (3rd GCs) have recently become controversial as the first-line strategy for empirical spontaneous bacterial peritonitis (SBP) treatment. This study aimed to identify SBP treatment efficacy predictors of 3rd GCs.Methods:In this retrospective cohort study, 279 cirrhosis patients with SBP who received 3rd GC monotherapy for initial empirical treatment from 2013 to 2019 were included. Nonresponse was defined as a decreased ascites polymorphonuclear (PMN) count < 25% from baseline after 48 hours of antibacterial treatment. Multivariate regression analysis was used to identify efficacy predictors of 3rd GCs in treating SBP. Kaplan–Meier analysis was used to evaluate survival data.Results:The nonresponder group included 120 patients with no response, and the responder group included 159 patients with responses. The response rate to 3rd GCs was 57.0% among all patients. The common pathogens were Escherichia coli (40.6%), Staphylococcus (15.6%), Klebsiella pneumonia (12.5%), and Streptococcus (12.5%) in 32 ascites culture isolates. Nosocomial SBP (NSBP) (odds ratio [OR]: 2.371, 95% confidence interval [CI]: 1.323–4.249, P = .004), pneumonia (OR: 11.561, 95% CI: 1.876–71.257, P = .008), recurrent SBP (OR: 3.386, 95% CI: 1.804–6.357, P < .001), platelet count (≥113.5 × 109/L) (OR: 3.515, 95% CI: 1.973–6.263, P < .001), and ascites PMN count (≤0.760 × 109/L) (OR: 4.967, 95% CI: 2.553–9.663, P < .001) were independent predictors of nonresponse to 3rd GCs against SBP. Survival plot analysis at 30 days showed worse survival for the nonresponders (P = .003).Conclusion:NSBP, pneumonia, recurrent SBP, increased platelet count, and lower ascites PMN count were independent predictors of nonresponse to 3rd GC in treating SBP. Nonresponse to initial antibiotic treatment was associated with worse survival.

Predictors of Recurrence of Spontaneous Bacterial Peritonitis in Cirrhotic Ascitic Patients

Predictors of Recurrence of Spontaneous Bacterial Peritonitis in Cirrhotic Ascitic Patients

Efficacy of Norfloxacin in secondary prophylaxis and profile of recurrent spontaneous bacterial peritonitis

Background and Aim: Secondary prophylaxis with norfloxacin reduces recurrence of spontaneous bacterial peritonitis (SBP) significantly. No data available from Asia-Pacific region about recurrence of SBP in these patients.

Rifaximin Vs. Norfloxacin for Spontaneous Bacterial Peritonitis Prophylaxis: A Randomized Controlled Trial

Spontaneous bacterial peritonitis (SBP) heralds increased mortality in cirrhosis, mandating strategies for prophylaxis. Norfloxacin has been the recommended choice for SBP prevention. However, its use has raised concerns about antibiotic resistance. Rifaximin has been suggested as an alternative. We investigated the efficacy of rifaximin against norfloxacin in primary and secondary prophylaxis of SBP. In this open-labeled randomized trial, patients with either advanced cirrhosis having ascitic fluid protein levels (<1.5g/l), Child-Pugh score ≥9 points, serum bilirubin ≥3mg/dl or impaired renal function (primary prophylaxis group), or those with prior SBP (secondary prophylaxis group) received either norfloxacin (400mg once daily) or rifaximin (550mg twice daily). All patients were followed for six months, with the primary endpoint being the development of incident SBP. 142 patients were assessed for eligibility, of which 132 met the enrolment criteria; 12 were lost to follow-up, while 4 discontinued treatment. In patients on primary prophylaxis, occurrence of SBP was similar (14.3% vs. 24.3%, P= 0.5), whereas in secondary prophylaxis SBP recurrence was lower with rifaximin (7% vs. 39% P= 0.004). Rifaximin significantly reduced the odds for SBP development in secondary prophylaxis [OR (95% CI0.14 (0.02-0.73; P= 0.02)]. Patients receiving rifaximin as secondary prophylaxis also had fewer episodes of hepatic encephalopathy (23.1% vs. 51.5%, P= 0.02). 180-day survival between the arms in either group was similar (P= 0.5, P= 0.2). In comparison to norfloxacin, rifaximin significantly reduces incident events of SBP, as well as HE when used as a secondary prophylaxis, whereas for primary prophylaxis both have similar effects(NCT03695705). ClinicalTrials.gov number: NCT03695705.

Norfloxacin with itopride versus norfloxacin alone in secondary prophylaxis of spontaneous bacterial peritonitis: a randomized trial

BackgroundBacterial translocation is considered the pathophysiological hallmark in the development of spontaneous bacterial peritonitis (SBP). Prokinetics can increase gastrointestinal (GIT) motility, reduce small bowel transit time, decrease bacterial translocation, and the possibility of SBP. The aim of this work was to compare the effectiveness and safety of itopride and norfloxacin versus norfloxacin only in secondary prophylaxis for cirrhotic ascitic patients with spontaneous bacterial peritonitis.ResultsRegarding the baseline clinical manifestations and laboratory investigations, there was no significant difference between both groups. The incidence of a recurrent SBP in group I, who had received itopride plus norfloxacin, reduced with a significant difference than other group II (P=0.018). The median time for recurrence of SBP was highly longer in group I than group II with a significant difference (P=0.042).ConclusionsThe combined usage of itopride with norfloxacin in patients with cirrhosis and ascites can decrease the occurrence of a recurrent SBP and significantly improve the survival of patients.Trial registrationClinicalTrials.gov Identifier: NCT04161768.

Liver Mobilisation during Recipient Hepatectomy Using Argon Plasma Coagulation - Tricks of Trade

Introduction: Recipient hepatectomy is one of the difficult and challenging procedure during liver transplant. Blood loss during recipient hepatectomy is one of the main determinants of outcome during liver transplant. In a patient with recurrent spontaneous bacterial peritonitis there are dense adhesion between liver and peritoneum which are highly vascularized. It is difficult to find plains for blood less dissection. In order to over come this problem we have developed our own technique of mobilization of liver. Methods: There are many energy devices available for blood less dissection during mobilization of liver. Right from electrocautery, bipolar, harmonic scalpel, ligasure, argon plasma coagulation and many more. We have developed our own technique for mobilization of liver when dense adhesions are present between liver and peritoneal area. We use APC for releasing right and left triangular ligament. Using gentle traction on liver and spraying APC between liver and adherent area. Results: With use of APC a blood less dissection is feasible perticulary in the areas where there is no clear plain for dissection. Moreover, it helps in prevention of rents of diaphragm. If dissection is done either with other devices there is need to dissect plain which leads to bleeding from newly formed collaterals and if they are used without dissection can lead to rents in diaphragm. Conclusion: A blood less dissection is feasible in recurrent SBP patient using APC.

Bacterial infections in cirrhosis: a narrative review and key points for clinical practice

Bacterial infections are frequent complications of liver cirrhosis, accounting for severe clinical courses, and increased mortality. The reduction of the negative clinical impact of infections may be achieved by a combination of prophylactic measures to reduce the occurrence, early identification, and management. Spontaneous bacterial peritonitis (SBP), urinary tract infections, pneumonia, cellulitis, and spontaneous bacteremia are frequent in cirrhosis. The choice of initial empirical antimicrobial therapy should be based on both site, severity, and origin of infection (community-acquired, nosocomial, or healthcare-associated) and on antibiotic resistance patterns. 3rd generation cephalosporins are generally indicated as empirical therapy in most community-acquired cases. However, for nosocomial and healthcare-associated infections, due to a high rate of multidrug-resistant (MDR) pathogens, a broader spectrum treatment is appropriate. In order to prevent antibiotic resistance emergence, microbiological cultures should be collected, and a de-escalation applied when antimicrobial susceptibility tests are available. Standard measures to prevent infections and the identification of carriers of MDR bacteria are essential strategies to prevent infections in cirrhosis. Antibiotic prophylaxis should be applied only to gastrointestinal bleeding, SBP recurrence prevention, and cirrhotics at high risk of a first episode of SBP.

Recurrent and Treatment-Unresponsive Spontaneous Bacterial Peritonitis Worsens survival in Decompensated Liver Cirrhosis

Spontaneous bacterial peritonitis (SBP) remains a major complication of cirrhosis. However, the incidence and the real impact of SBP in determining patient survival rates remain unclear. This study aims to evaluate the incidence and risk factors for SBP development and the role of SBP in predicting transplant-free survival. Two hundred two consecutive patients underwent 492 paracenteses with biochemical and microbiological analysis of the ascitic fluid. When multiple paracenteses had been performed on a given patient, the first SBP-positive paracentesis or the first paracentesis conducted when none was diagnostic for SBP was included in the study. SBP was detected in 28 of 202 (13.9%) patients; in 26 of 28 patients, the neutrophil count in the ascitic fluid was ≥250 cells/μl, and in 15 of 28 patients, the cultures were positive. Variables independently associated with SBP were as follows: a higher model of end-stage liver disease (MELD) score, the serum glucose value, elevated CRP serum levels, and higher potassium serum levels. Overall, the median (range) transplant-free survival was 289 (54-1253) days. One hundred (49.5%) patients died, whereas 35 patients (17.3%) underwent liver transplantation. Independent predictors of death or liver transplantation were a higher MELD score and the development of SBP, especially if it was antibiotic-resistant or recurrent SBP. The occurrence of SBP is associated with more severe liver dysfunction in conjunction with the presence of inflammation. Unlike the occurrence of SBP per se, failure of first-line antibiotic treatment and SBP recurrence appear to strongly influence the mortality rate.

Recurrence of spontaneous bacterial peritonitis in cirrhosis: novel predictors.

Recurrence of spontaneous bacterial peritonitis (SBP) is still a matter of debate. We conducted this study to evaluate the probable factors that predict the recurrence of SBP in patients who recovered from the first episode of SBP and the long-term outcomes of SBP recurrence. One hundred twenty-four patients diagnosed with liver cirrhosis, SBP and did not receive secondary prophylaxis either with norfloxacin or other antibiotics were included in this prospective cohort pilot study. Clinical, biochemical and ascitic fluid analysis parameters were evaluated. Ascitic fluid interferon-γ-induced protein (IP-10), calprotectin, interleukin-6 and tumor necrosis factor-α were measured by ELISA. Of these, 76 patients survived with an in-hospital mortality rate of 38.7%. The survivors were classified into two groups according to recurrence and nonrecurrence of SBP and survival time, clinical parameters and cause of death were investigated. Thirty-one participants had one or more attacks of SBP, with a recurrence rate of 40.8% within one-year follow-up. Before discharge, multivariate analysis showed that ascitic IP-10 (≥1220 pg/ml), ascitic calprotectin (≥550 ng/ml), serum albumin (≤2.5 g/dl), nonuse of prophylactic β-blockers and use of proton-pump inhibitors (PPIs) were the independent variables in predicting recurrent SBP. Sepsis-related organ failure was the most common etiology of mortality in the recurrent SBP group within 3 and 6 months. Increased ascitic calprotectin and IP-10, hypoalbuminemia, nonuse of prophylactic β-blockers and use of PPI were independently associated with increased SBP recurrence rate. Sepsis-related organ failure was the most common etiology of mortality.

Factors that predict recurrent spontaneous bacterial peritonitis in cirrhotic patients.

The recurrence rate of spontaneous bacterial peritonitis (SBP) is increasing in cirrhotic patients. Antibiotic prophylaxis should be prescribed in all cirrhotic patients after the first episode of SBP. However, antibiotics promote the development of antibiotic-resistant bacteria. To identify the factors that predict the recurrence of SBP after the first episode in cirrhotic patients to optimise the stratification for secondary antibiotic prophylaxis. This retrospective study included 145 cirrhotic patients who had their first SBP episode during 2011-2015. The 86 patients who survived were divided into either the SBP recurrence or non-recurrence group according to patient SBP outcome during the 2-year follow-up. Demographical, clinical and laboratory parameters were recorded at SBP diagnosis and before hospital discharge. SBP recurrence rate, recurrence-free survival and in-hospital mortality were also analysed. The recurrence rate of SBP after the first episode was 69.8% (60/86), and the median recurrence-free survival time was 142days. The in-hospital mortality rate was 40.7% (59/145). The significant predictive factors for recurrence of SBP were serum potassium≥4mEq/L (HR: 1.89; P=.028), serum albumin≤2g/dL (HR: 2.5; P=.003) at diagnosis of SBP and platelet count before discharge≤100000/microliter (HR: 1.93; P=.029). SBP frequently recurs in cirrhotic patients. Serum potassium≥4mEq/L, serum albumin≤2g/dL at SBP diagnosis and platelet count≤100000/microliter before discharge were identified as factors that may predict the recurrence of SBP after the first episode.

Predictors of early recipient mortality after living donor liver transplantation in a tertiary care center in Egypt.

ABSTRACTBACKGROUND: Living donor liver transplantation (LDLT) has evolved into a widely accepted therapeutic option. Many different risk factors may affect early mortality after LDLT.OBJECTIVES: Analyze risk factors that can affect early (<6 months) mortality of patients after LDLT in a single center.DESIGN: Retrospective chart review of patients who underwent LDLT.SETTING: University hospital.PATIENTS AND METHODS: Adult cirrhotic patients who underwent LDLT were classified by early (first 6 months) or late mortality. A full pre, intra- and post-operative evaluation had been done on all patients including a full history, examination and investigations to identify risk factors that might affect mortality post-LDLT.MAIN OUTCOME MEASURES: Determination of pre-, intra- or postoperative factors that might affect recipient mortality post-LDLT.SAMPLE SIZE: 123.RESULTS: Pre-operative factors that increased early mortality in a univariate analysis were higher model for end-stage liver disease (MELD) scores, lower graft-recipient weigh ratio (GRWR), older donor age, and recurrent spontaneous bacterial peritonitis. Intraoperative factors included more transfusion units of blood, plasma, platelets and cryoprecipitate, a longer time for cold and warm ischemia, and a longer anhepatic phase among others. Postoperative factors included a longer ICU or hospital stay and abnormal postoperative laboratory data. In the final logistic regression model, the most significant factors were pre-operative GRWR, length of hospital stay, units of intraoperative blood transfusion, postoperative alanine aminotransferase, postoperative total leukocyte count, and MELD score.CONCLUSION: LDLT outcomes might be improved by attempting to resolve clinical factors that have been identified as contributors to early post-LDLT mortality.LIMITATIONS: More risk factors, such as those relevant to patient portal vein hemodynamics, should be included in an analysis of predictors of early mortality.CONFLICT OF INTEREST: None.

Spontaneous bacterial peritonitis recurrence in patients with cirrhosis receiving secondary prophylaxis with norfloxacin.

Few studies carried out more than 20 years ago have evaluated spontaneous bacterial peritonitis (SBP) recurrence in patients receiving secondary antibiotic prophylaxis. These studies reported a 1-year recurrence rate of 20-26%. Changes in the bacteriology of SBP over the last few years might have negative effects on secondary prophylaxis. Our primary aim was to estimate the incidence of SBP recurrence in patients with cirrhosis receiving secondary prophylaxis with norfloxacin and to explore the factors associated with SBP recurrence. This was a retrospective cohort study of patients receiving norfloxacin for the secondary prophylaxis of SBP from 1 March 2003 to 31 March 2016. Follow-up was performed for 365 days after secondary prophylaxis was started. A competing risk analysis approach was used. A total of 115 patients were included. The prevalence of quinolone-resistant and multiresistant bacteria in the first episode of SBP among patients with culture-positive SBP was 70.96% [95% confidence interval (CI): 51.96-85.77%] and 12.90% (95% CI: 3.63-29.83%), respectively. The cumulative incidence of SBP recurrence was 28.53% (95% CI: 20.15-37.45%) after 365 days. Male patients showed an estimated subhazard ratio of SBP recurrence of 2.52 (95% CI: 1.07-5.91, P=0.034). No other risk factors for SBP recurrence were identified. The overall cumulative incidence of death after 365 days was 21.57% (95% CI: 14.14-30.04%), without significant differences among patients with or without SBP recurrence. Even though changes in the bacteriology of SBP occurred over time, its recurrence rate in patients receiving norfloxacin remains similar to what was reported in the initial studies.

Initial choice of antibiotic in recurrent spontaneous bacterial peritonitis: A retrospective study.

Context:Spontaneous bacterial peritonitis (SBP) is a commonly encountered infection seen in the setting of ascites secondary to advanced liver disease. Recurrence of SBP is common and is associated with high mortality. This study was designed to recognize a better initial choice of antibiotic in case of recurrent SBP – a third-generation cephalosporin or a carbapenem.Aims:This study aims to determine a better initial choice of antibiotic in case of recurrent SBP and to compare the all-cause mortality among two different groups of patients treated with a third-generation cephalosporin and a carbapenem.Settings and Design:This study was conducted among fifty patients presenting with recurrent SBP visiting the emergency department (ED) at a tertiary care center and who were subsequently admitted in a gastroenterology intensive care unit, during a period of 1 year.Subjects and Methods:This is a retrospective, observational study conducted among patients with chronic liver disease and diagnosed with recurrent SBP visiting the ED at a tertiary care center in South India treated with either of two classes of antibiotics – third-generation cephalosporins or carbapenems, and their outcomes were compared. Recurrence is defined as an episode of SBP after resolution of the first index case of SBP within 1 year.Statistical Analysis Used:Statistical analysis was done using IBM SPSS version 23.0 (SPSS Inc., Chicago, IL, USA). All categorical variables were represented as percentages, and all continuous variables were represented as mean ± standard deviation. To test the statistical significance of the association of categorical variables with the outcome, Chi-square test was used. P <0.05 was considered statistically significant.Results:A total of fifty patients with recurrent SBP were included in the study, of which 44 (88%) patients were male and 6 patients were female (12%). Twenty-nine (58%) patients survived and 21 (42%) patients expired within 28 days. Twenty-seven (54%) patients were treated with third-generation cephalosporins and 23 (46%) were treated with carbapenems. It was observed that mortality was statistically significantly lower among patients treated with carbapenem (P = 0.001). The incidence of acute kidney injury was also lower among patients treated with a carbapenem than patients treated with a third-generation cephalosporin (40.7% vs. 59.25%, respectively).Conclusions:Initiation of a carbapenem significantly reduced the all-cause mortality when compared to a third-generation cephalosporin as an initial antibiotic of choice in recurrent SBP.

Weekly Ciprofloxacin vs. Daily Norfloxacin for Preventing Spontaneous Bacterial Peritonitis Recurrence

For treatment of spontaneous bacterial peritonitis (SBP) as a complication of ascites due to cirrhosis, the current standard of practice is to start

15. Predictors of recurrent spontaneous bacterial peritonitis in patients with cirrhosis of liver

Background and Aims: Spontaneous bacterial peritonitis (SBP) a common bacterial infection with high mortality is an important milestone in the natural history of Chronic liver disease. The problem of recurrent SBP is emerging and studies on the risk factors of recurrent SBP are limited. We aim to assess the factors responsible for recurrent SBP in hospitalized cirrhosis patients and to study the impact of recurrent SBP on mortality. Methods: This is a prospective cohort study done over one year, where patients admitted with SBP were enrolled and their clinical, endoscopic, biochemical parameters and survival time were analyzed. Results: There were 111 cases of SBP of which 45 (40.5%) were recurrent SBP. The whole study group was divided into two groups based on first episode and recurrent SBP. Univariate analysis showed presence of fever on admission (p = 0.04), history of ascites (p = 0.00), history of other infections (p = 0.05), hepatic encephalopathy (p = 0.016), diuretic use (p = 0.00), SBP prophylaxis (0.00), recent (<30 days) antibiotic use (p = 0.04), repeated therapeutic paracentesis (p = 0.00), higher Child Pugh score (p = 0.001), MELD score (p = 0.00), higher grade of esophageal varix (p = 0.031), presence of portal hypertensive gastropathy [PHG] (p = 0.00), bilirubin level (p = 0.00), Serum creatinine (p = 0.05), ascitic fluid albumin (p = 0.005) were significantly different between the groups. Using logistic regression model for multivariate analysis PHG, ascitic fluid albumin, bilirubin were independent predictors of recurrent SBP, [p = 0.001, odds ratio (OR) = 0.086, 95% confidence interval (CI) 0.023–0.354 for PHG; p = 0.03 OR = 3.84; 95% CI, 1.11–13.96 for ascitic fluid albumin and p = 0.043 OR = 0.28, 95% CI, 0.074–0.986 for bilirubin]. The mortality was 73.3% (33/45) in recurrent group (p = 0.009). Kaplan Meir survival with Cox regression analysis showed mean survival of 379 ± 61 in first SBP group as compared to 99 ± 8 in recurrent group (p = 0.04). Conclusions: Recurrent SBP is associated with high mortality and lesser survival as compared to single episode of SBP. Presence of PHG, ascitic fluid albumin, serum bilirubin can be useful to predict the recurrence of SBP. The author has none to declare.

The Predictive Factors for Recurrence of Spontaneous Bacterial Peritonitis

The Predictive Factors for Recurrence of Spontaneous Bacterial Peritonitis

Prevalence of Spontaneous Bacterial Peritonitis in Ecuadorian Patients With Decompensated Liver Cirrhosis

Introduction: The prevalence of spontaneous bacterial peritonitis (SBP) in Ecuador is uncertain because studies that allows to observate how this disease is performing and evolving have never been done before. The purpose of this study is to determine the prevalence of SBP episodes in Ecuadorian patients with decompensated liver cirrhosis during a one year period and its association with clinical symptoms, laboratory findings and bacterial pathogens. Methods: A cross-sectional study was conducted in sixty-one Ecuadorian patients who met the inclusion criteria with decompensated liver cirrhosis and ascites during the period between December 2014-December 2015. These patients underwent diagnostic and/or therapeutic paracentesis, whose ascites fluid obtained were analyzed and cultured. Results: A total of 280 paracentesis were performed in 61 patients with a mean of 4.59 paracentesis per patient. Only 63 were classified as SBP, with a mean of one episode of SBP per patient indicating a prevalence of 45%. The majority of patients were male (66%). The most common cause of cirrhosis was NASH (49%). Turbid ascitic liquid was highly seen (SBP: 81%, not SBP: 57%). The most frequent manifestation was abdominal pain (43%) followed by hepatic encephalopathy (41%). With regard to the presentation of SBP, 73% had an increased cell count plus negative cultures and only 27% had positive cultures. The average mortality was 52%, which became higher in patients who had more than one episode of SBP (Odds Ratio: 0.83 and probability of mortality of 45%) Conclusion: It was striking that the most frequent cause of cirrhosis in Ecuadorian patients was due to NASH because in the majority of international statistics the main cause of cirrhosis is hepatitis C virus. Despite being an infectious complication, fever was not a frequent clinical manifestation. Among the characteristics of fluid we can learn that the presence of turbid liquid is not necessarily related to infection, since the proportion of this characteristic was similar in the infected as in the non-infected groups. As E.coli was most commonly identified and there was an important percentage of patients with recurrent SBP episodes, the use of empirical antibiotic therapy against this agent can be an effective prophylaxis strategie. The high prevalence of SBP in our environment and associated mortality requires a study with a larger number of patients to obtain more significant results and have a better understanding in the implications of SBP in Ecuadorian population.Table: Table. Causes of CirrhosisTable: Table. General SummaryFigure: INCLUSION AND EXCLUSION CRITERIAS.